| Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China | Lancet, The | 2020 | 25.2K |
| Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study | Lancet, The | 2020 | 15K |
| A novel coronavirus outbreak of global health concern | Lancet, The | 2020 | 3.7K |
| A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19 | New England Journal of Medicine | 2020 | 3.3K |
| Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial | Lancet, The | 2020 | 2.1K |
| Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia | Journal of Thrombosis and Haemostasis | 2020 | 1K |
| SARS-CoV-2 and viral sepsis: observations and hypotheses | Lancet, The | 2020 | 646 |
| On the use of corticosteroids for 2019-nCoV pneumonia | Lancet, The | 2020 | 399 |
| Critical care crisis and some recommendations during the COVID-19 epidemic in China | Intensive Care Medicine | 2020 | 311 |
| The future of cystic fibrosis care: a global perspective | Lancet Respiratory Medicine,the | 2020 | 259 |
| Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak | Journal of Medical Virology | 2020 | 236 |
| Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China: Prevalence, Risk Factors, and Outcome | Circulation | 2020 | 235 |
| Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines | Thrombosis and Haemostasis | 2020 | 221 |
| Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study | Critical Care | 2020 | 208 |
| Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China | JAMA Network Open | 2020 | 206 |
| Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1 | Chest | 2020 | 197 |
| Detection of COVID-19: A review of the current literature and future perspectives | Biosensors and Bioelectronics | 2020 | 162 |
| Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence | Journal of Allergy and Clinical Immunology | 2020 | 104 |
| Technical standards for respiratory oscillometry | European Respiratory Journal | 2020 | 96 |
| Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study | Intensive Care Medicine | 2020 | 86 |
| Allergic rhinitis | Nature Reviews Disease Primers | 2020 | 85 |
| Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019 | Chinese Medical Journal | 2020 | 84 |
| Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement | Allergy: European Journal of Allergy and Clinical Immunology | 2020 | 81 |
| Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine | Thrombosis and Haemostasis | 2020 | 73 |
| Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study | Critical Care Medicine | 2020 | 72 |
